Loss of royalty income from major customer dents Immunodiagnostic’s profits

04:37 EDT 20 Jun 2018 | Proactive Investors

Immunodiagnostic develops and sells assays (tests) which can help doctors to identify everything about their patient, from what they are allergic to right through to why they are struggling to get pregnant

More From BioPortfolio on "Loss of royalty income from major customer dents Immunodiagnostic’s profits"